To hear about similar clinical trials, please enter your email below
Trial Title:
Opportunistic Gastric Cancer Screening
NCT ID:
NCT06316882
Condition:
Gastric Cancer
Conditions: Official terms:
Stomach Neoplasms
Conditions: Keywords:
Gastric Cancer
Endoscopic screening
intermediated risk countries
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Screening
Masking:
None (Open Label)
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
Screening endoscopy
Description:
We perform upper endoscopy, when the patient authorizes it, during their screening
colonoscopy
Arm group label:
screening endoscopy
Other name:
upper endoscopy
Summary:
Endoscopic screening of gastric cancer combined with screening colonoscopy
Detailed description:
A local prospective cohort study will be developed to test the theoretical
cost-effectiveness model of endoscopic gastric cancer screening, at the same time as
colorectal cancer screening colonoscopy in an European intermediate-risk country The
investigators propose that patients who have a screening colonoscopy scheduled undergo
simultaneously screening upper endoscopy with biopsies.
This study is conducted by 3 investigators in 2 Hospitals of Unidade Local de Saúde do
Norte Alentejano, em Portugal.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- people who agree to undergo endoscopic screening for gastric cancer;
- people who undergo screening colonoscopy
Exclusion Criteria:
- Exams without biopsies
Gender:
All
Minimum age:
40 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
ULSNA
Address:
City:
Portalegre
Zip:
7300-853
Country:
Portugal
Status:
Recruiting
Contact:
Last name:
Beatriz Mourato, MD
Phone:
00351910311213
Email:
2091@ulsna.min-saude.pt
Investigator:
Last name:
Beatriz Mourato, MD
Email:
Principal Investigator
Investigator:
Last name:
Guilherme Santos, MD
Email:
Principal Investigator
Investigator:
Last name:
Sara Morais, MD
Email:
Sub-Investigator
Investigator:
Last name:
Nuno Pratas, MD
Email:
Principal Investigator
Investigator:
Last name:
Filipa Taré, MD
Email:
Principal Investigator
Start date:
February 3, 2023
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Unidade Local De Saúde Do Norte Alentejano
Agency class:
Other
Collaborator:
Agency:
NOVA Medical School
Agency class:
Other
Source:
Unidade Local De Saúde Do Norte Alentejano
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06316882
https://gco.iarc.fr/today/online-analysis-map?v=2020&mode=population&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=7&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=0&include_nmsc_other=0&projection=natural-earth&color_palette=default&map_scale=quantile&map_nb_colors=5&continent=0&show_ranking=0&rotate=%255B10%252C0%255D
https://portal.gdc.cancer.gov
